Circulating microRNA-26a: Potential predictors and therapeutic targets for non-hypertensive intracerebral hemorrhage

Medical Hypotheses

Volumn 77, Issue 4, 2011, Pages 488-490

  Bai, Yongyi ^a   Wang, Liang ^a   Sun, Lan ^b   Ye, Ping ^a   Hui, Rutai ^b,c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COL4A1 PROTEIN; COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; MICRORNA; MICRORNA 26A; PLATELET DERIVED GROWTH FACTOR D; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTERIOLOSCLEROSIS; ARTICLE; BASEMENT MEMBRANE; BRAIN HEMORRHAGE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; GENE EXPRESSION; GENE MUTATION; GENE REPRESSION; HUMAN; NONHUMAN; PREDICTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSLATION REGULATION; VASCULAR AMYLOIDOSIS; VASCULAR SMOOTH MUSCLE;

CEREBRAL HEMORRHAGE; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR;

EID: 80052639532     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.06.017     Document Type: Article

References (27)

1. Liu M., Wu B., Wang W.Z., et al. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 2007, 6:456-464.
2. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994, 90:583-612.
3. Reed D.M. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990, 131:579-588.
4. National 8.5 CVD collaborative Group. Community comprehensive preventive study on cardial and cerebral vascular diseases. Chin J Prevent Med 1998;32(Suppl.):3-4.
5. Shi F.L., Hart R.G., Sherman D.G., et al. Stroke in the People's Republic of China. Stroke 1989, 20:1581-1585.
6. He J., Klag M.J., Wu Z., et al. Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors. Stroke 1995, 26:2222-2227.
7. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
8. Yang Q.D., Niu Q., Zhou Y.H., et al. Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000. Cerebrovasc Dis 2004, 17:303-313.
9. Woo D., Sauerbeck L.R., Kissela B.M., et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002, 33:1190-1195.
10. Li Z., Sun L., Zhang H., et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicenter case-control study in China. Stroke 2003, 34:2085-2090.
11. Rost N.S., Greenberg S.M., Rosand J. The genetic architecture of intracerebral hemorrhage. Stroke 2008, 39:2166-2173.
12. Qureshi I.A., Mehler M.F. The emerging role of epigenetics in stroke: II. RNA regulatory circuitry. Arch Neurol 2010, 67:1435-1441.
13. Greenberg S.M. Small vessels, big problems. N Engl J Med 2006, 354:1451-1453.
14. Gavornik P., Galbavy S. Clinical picture of arteriolosclerosis. Bratisl Lek Listy 2001, 102:326-331.
15. Soffer D. Cerebral amyloid angiopathy - a disease or age-related condition. Isr Med Assoc J 2006, 8:803-806.
16. Perlmutter L.S. Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol Neurobiol 1994, 9:33-40.
17. Mok S.S., Losic D., Barrow C.J., et al. The beta-amyloid peptide of Alzheimer's disease decreases adhesion of vascular smooth muscle cells to the basement membrane. J Neurochem 2006, 96:53-64.
18. Romanic A.M., White R.F., Arleth A.J., et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998, 29:1020-1030.
19. Gould D.B., Phalan F.C., van Mil S.E., et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006, 354:1489-1496.
20. LaRochelle W.J., Jeffers M., McDonald W.F., et al. PDGF-D, a new protease-activated growth factor. Nat Cell Biol 2001, 3:517-521.
21. Wågsäter D., Zhu C., Björck H.M., et al. Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 2009, 202:415-423.
22. Pontén A., Folestad E.B., Pietras K., et al. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circ Res 2005, 97:1036-1045.
23. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
24. LeeY S., Dutta A. MicroRNAs in cancer. Annu Rev Pathol 2009, 4:199-227.
25. Leeper N.J., Raiesdana A., Kojima Y., et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011, 226:1035-1043.
26. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
27. Liu D.Z., Tian Y., Ander B.P., et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 2010, 30:92-101.